부채 변화 날짜
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 57.3B 19M 2026-06
Bayer EUR 36.45B 2.93B 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Cipla INR 6.99B 857M 2026-09
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 3.02M 91K 2026-06
CSL USD 11.96B 219M 2024-12
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Grifols EUR 9.23B 626.05M 2024-12
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
J&J USD 49.04B 5.95B 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Merck USD 53.91B 4.79B 2026-06
Novartis USD 49.01B 2.02B 2026-06
Omeros USD 442.16M 199K 2023-09
Pfizer USD 62.67B 523M 2026-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09